Aerie Pharmaceuticals Logo

Inspiration. Imagination. Innovation.

Aerie Pharmaceuticals is an ophthalmic pharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies for the treatment of patients with glaucoma, retinal diseases and other diseases of the eye.

We have a passion for finding new approaches for protecting or improving vision. United by VISIONaerie® Science, deep clinical insights, and a singular focus on addressing the unmet needs in ophthalmology, we see the possibilities ahead. Join us in creating the future of eye care.

Photo of Dr. David L. Epstein (MD), Co-Founder of Aerie Pharmaceuticals Inc.

OUR SCIENTIFIC HERITAGE

From an idea that started at Duke University, we have built a company committed to innovation in eye care.

MORE
Aerie Pharmaceuticals leadership team

OUR LEADERSHIP

Meet the eye care VISIONaerieS® building the next major ophthalmic pharmaceutical company.

MORE
Aerie Pharmaceuticals Board of Directors

OUR BOARD OF DIRECTORS

In our pursuit of scientific, clinical, and operational excellence, we are guided by some of the best minds in the healthcare industry.

MORE
TOP